Boehringer Ingelheim is committed to becoming the most innovative research, development and distribution enterprise in the world, providing products that significantly enhance health and quality of life.
Currently investigating therapies for over 22 acute and chronic conditions that drive up US health care costs.
17% net sales to R&D
Family owned – Boehringer
Founded in Ingelheim / Germany in 1885
156 affiliates in over 60 countries
Focus on Human Pharmaceuticals – 95%
Prescription medicines – Brand and Generic
Pharmaceutical R&D BIPKG (Karl Thomae) Boehringer Ingelheim Pharmaceuticals BI Austria Boehringer Ingelheim , KG Nippon Boehringer (Allergy, Biotechnology) (Immunology, Inflammation, Cardiovascular) (Virology) BI Canada (Oncology) (Respiratory, CNS, Metabolic Diseases)
BIC Companies - 6,000 employees Roxane Laboratories, Inc. Columbus, OH Boehringer Ingelheim Corporation Boehringer Ingelheim Pharmaceuticals, Inc. BI Services Center, Inc. Boehringer Ingelheim Cares Foundation, Inc. Ridgefield, CT 2,300 employees BI Vetmedica St. Joseph, MO Boehringer Ingelheim Chemicals, Inc. Petersburg, VA Ben Venue Labs Bedford, OH
US Statistics (2005 Projected)
Net Sales $ 4.2 billion +31%
Employees in US 6,000
Employees in Danbury/Ridgefield 2,300 +14%
Expected employee growth in CT 750
(over next seven years)
Products in the US
Brand Prescription Medicines
Chronic Obstructive SPIRIVA , COMBIVENT, ATROVENT
Virology (HIV/AIDS) VIRAMUNE, APTIVUS
Cardiology MICARDIS, AGGRENOX, CATAPRES
Generic Prescription Medicines
Over 200 products with specialties in anti–cancer, sterile injectables and sterile respiratory therapies
Assisting the Community
BI Cares Foundation
The Foundation’s mission is to improve lives through innovative philanthropic contributions and donations of healthcare products and resources.
BI Cares Foundation Patient Assistance Plan.
Hurricane Katrina assistance.
Product Donation Program.
Community Involvement - CT
Lung Health Screening Program
United Way of Northern Fairfield County
Regional Hospice of Western Connecticut
American Red Cross
Connecticut PBS – Family Science Expo
Abilities Beyond Disabilities (DATAHR)
Connecticut United for Research Excellence
Ives Center for the Arts
Girl Scout Council of SW Connecticut
Regional YMCA Center for Arts & Humanities
Special Olympics – Connecticut
Western Connecticut State University
Growth for the Future
Ridgefield campus projects
Lead Discovery Technologies Building dedicated in 2001
Completed in 2005, produces drug substances up to 5 kg quantities for research purposes.
On-site Child Care Center; September 2006
19,000 sq ft stand alone building with a capacity for 256 infants, toddlers and preschoolers.
Physical Sciences building; March 2007
86,000 sq ft building to accommodate relocation of our cardiovascular diseases research program from Germany.
3 floors, 119 work stations for scientists and management.
Needs for the future
Vibrant biopharmaceutical industry in CT
Public private sector collaborations
Clinical trials centers of excellence
Prescription drug importation
AKA price controls
Inability to generate interest in new products
Inability to gain market share
Increased costs of doing business
Energy, taxes, fees, liability
http://www.boehringer-ingelheim.com Worldwide web
http://us.boehringer-ingelheim.com US company web
https://www.pparx.org/Intro.php Partnership for Prescription Assistance
http://us.boehringer-ingelheim.com/about/philanthropy/Patient_Assistance_Program.html BI Cares Foundation Patient Assistance web